High-intensity Interval Training in Patients With Atrial Fibrillation
HIIT-AF
Impact of High-intensity Interval Training in Patients With Atrial Fibrillation: Understanding of the Underlying Cardiovascular Mechanisms
1 other identifier
interventional
150
1 country
1
Brief Summary
A key characteristic of the heart is its regular rhythm. When the heart is exposed to irregular electric impulses, such as with atrial fibrillation (AF), detrimental effects can occur affecting the ability of the heart to pump blood. AF affects more than 33 million individuals worldwide, and places individuals at increased risk for stroke, heart failure and death. Of note, being fit seems to protect the long-term severity of AF, and individuals with AF who improved their aerobic fitness seem to decrease their severity of atrial fibrillation. Although exercise training is known to improve aerobic fitness, there are limited data investigating the benefits of an exercise training program on the reduction of AF burden. Once AF is present, regular exercise in these patients reduces the risk for developing cardiovascular events. Moreover, exercise training at high-intensity seems to bring greater adaptations in cardiac patients. This effect may be related to improvements in cardiovascular function and structure. No previous study has explored this possibility in patients with AF. Therefore, I will assess cardiac function and blood vessel quality before and after exercise training (at high- and moderate-intensities) in patients with AF. Better insight into how intensity of exercise training could affect the heart and the blood vessels can lead to better exercise recommendations in this population. This project will contribute to improved clinical care for patients with AF, specifically related to the prescription of the optimal dose and type of exercise. This may result in fewer complications, improved quality of life, and lower socio-economic/healthcare costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable atrial-fibrillation
Started Aug 2021
Shorter than P25 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 27, 2021
CompletedFirst Submitted
Initial submission to the registry
December 2, 2021
CompletedFirst Posted
Study publicly available on registry
April 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 27, 2023
CompletedApril 29, 2022
November 1, 2021
1.4 years
December 2, 2021
April 26, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in burden of atrial fibrillation
Burden of atrial fibrillation (number of episodes) continually measured, and reported by the patient. Measured by Huawei Band 4 and 6
baseline and 3 months post rhythm control procedure
Secondary Outcomes (13)
Maximal oxygen uptake
baseline and 3 months post rhythm control procedure
Peripheral endothelial function
baseline and 3 months post rhythm control procedure
Carotid structure
baseline and 3 months post rhythm control procedure
Central endothelial function
baseline and 3 months post rhythm control procedure
Health related quality of life
baseline and 3 months post rhythm control procedure
- +8 more secondary outcomes
Study Arms (3)
High-intensity interval training
EXPERIMENTALPatients will cycle or walk/run four intervals of four-min at high intensity with the aim to reach 80-90% of peak oxygen consumption, 90-95% of peak heart rate, 15-17 Borg scale, shortness of breath). Each interval is separated by a three-min active recovery, at 50-60% of peak oxygen consumption or 70-75% of peak heart rate. Total exercise time will be 38 min including the warm-up and cool-down.
Moderate-intensity continuous training
ACTIVE COMPARATORPatients will cycle or walk/run continuously at moderate intensity (50-60% of peak oxygen consumption, 70-75% of peak heart rate) for 37 min. Total exercise time will be 47 min for the moderate-intensity continuous training group including warm-up and cool-down (isoenergetic compared to high-intensity interval training).
Control
NO INTERVENTIONThe control group will continue their habits without increasing the level of physical activity nor participate to any supervised exercise training.
Interventions
Patients will cycle or walk/run four intervals of four-min at high intensity with the aim to reach 80-90% of peak oxygen consumption, 90-95% of peak heart rate, 15-17 Borg scale, shortness of breath). Each interval is separated by a three-min active recovery, at 50-60% of peak oxygen consumption or 70-75% of peak heart rate. Total exercise time will be 38 min including the warm-up and cool-down.
Patients will cycle or walk/run continuously at moderate intensity (50-60% of peak oxygen consumption, 70-75% of peak heart rate) for 37 min. Total exercise time will be 47 min for the Moderate-intensity continuous training group including warm-up and cool-down (isoenergetic compared to high-intensity interval training).
Eligibility Criteria
You may qualify if:
- Presence of non-permanent AF
- \> 18 years old
You may not qualify if:
- Performing endurance training at high intensity \>2 times/week or at moderate intensity \>3 times/week;
- Previous cardiac surgery not related to AF;
- LVEF \<45%;
- Severe coronary artery disease non-suitable for revascularization;
- Significant cardiac valve disease;
- Implanted cardiac pacemaker;
- And restriction to cardiopulmonary exercise testing or severe intolerance to exercise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liverpool John Moores Universitylead
- Liverpool Heart and Chest Hospital NHS Foundation Trustcollaborator
- Liverpool Centre for Cardiovascular Sciencecollaborator
- University of Liverpoolcollaborator
Study Sites (1)
Liverpool Centre for Cardiovascular Sciences
Liverpool, Merseyside, L14 3PE, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2021
First Posted
April 29, 2022
Study Start
August 27, 2021
Primary Completion
January 27, 2023
Study Completion
January 27, 2023
Last Updated
April 29, 2022
Record last verified: 2021-11